AzTrials
AzTrials

Airway Complication of AnesthesiaNCT03395782

Factors Determining Oxygen Wash in During Pre-oxygenation

An observational study of Airway Complication of Anesthesia, run by Region Västmanland at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Earlier studies has shown a correlation between older age and longer time for the rise in the end-tidal O2 concentration during pre-oxygenation. In this study the investigators aim to analyse this correlation more closely and investigate if the arterial partial pressure of oxygen (PaO2) as measured before the start of… Read more about this study

Who is it for?
Ages 40 to 79 years
Conditions the study is for
Airway Complication of Anesthesia
How many people
120 participants
Where
1 siteSweden
Study dates
30 Oct 2018to 29 Sep 2021
How long will I take part?
1 Day
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 79 years
  • All sexes
  • Adult, Older adult

Study population: Patients scheduled for elective surgery in general anaesthesia.

Who may be able to join

  • Patients scheduled for general anaesthesia in American Society of Anesthesiology (ASA) physical status classification grade I-III.
  • Body mass index over 18.5 and less than 30 kg/m2
  • Peripheral oxygen saturation 92% or more on air.

Who cannot join

  • ASA IV.
  • Patients with active smoking and former smokers with a history of smoking more than 6 pack-years.
  • Chronic obstructive lung disease.
  • Bloodgas with PaO2 ≤ 8 kilopascal (kPa) or PaCO2 ≥ 6.5 kPa.
  • Continuous positive airway pressure treatment at night.
  • Heart failure or angina pectoris.
Show all 12Show fewer
  • Hemoglobin value less than 100 g/L.
  • Pregnancy.
  • Any neuromuscular or neurologic illness reducing ventilatory capacity.
  • Any endocrine disease influencing basic metabolic demand.
  • Not possible to achieve a tight mask seal.
  • Patient unable to follow instructions.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Köping County Hospital

    Köping, Västmanland County, 73130

Other trials in Sweden

About this study

Official title: Factors Determining End-tidal O2 Concentration in During Pre-oxygenation

Earlier studies has shown a correlation between older age and longer time for the rise in the end-tidal O2 concentration during pre-oxygenation. In this study the investigators aim to analyse this correlation more closely and investigate if the arterial partial pressure of oxygen (PaO2) as measured before the start of pre-oxygenation, with the patient breathing air, is a better predictor than age for estimating the time necessary for achieving the goal of pre-oxygenation.

Read the detailed description

Before induction of general anaesthesia pre-oxygenation is a recommended procedure to enhance the time available for solving a problem with the airway or intubation during induction. This can be accomplished by letting the patient breath normal tidal volumes with 100% oxygen for 3 to 5 minutes during pre-oxygenation. If there is airway closure during tidal volume breathing, pre-oxygenation needs longer time to achieve a maximum effect. Airway closure increases with advanced age and a few earlier studies has also shown a correlation between older age and longer time for the rise in the end-tidal O2 concentration during pre-oxygenation.

Pre-oxygenation is a strongly recommended safety procedure before starting anaesthesia but has at least one major side affect: it is the main reason for the development of atelectasis in the lungs during anaesthesia. Atelectasis impairs oxygenation during anaesthesia and probably increase the risk for postoperative pulmonary complications.

Postoperative complications are more common with advanced age and it is important to understand the mechanisms and risk factors involved.

In this study, the investigators hypothesise that the PaO2 as measured before the start of pre-oxygenation, with the patient breathing air, is a better predictor than age for estimating the time necessary for achieving the goal of pre-oxygenation. If this assumption is correct it might have implication for how pre-oxygenation should be adjusted with advancing age.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03395782
Study groupRoleWhat they receive
Age group 40-4930 patients will be stratified to this age group.
Age group 50-5930 patients will be stratified to this age group.
Age group 60-6930 patients will be stratified to this age group.
Age group 70-7930 patients will be stratified to this age group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PaO2 breathing air before start of pre-oxygenation and the rise in end-tidal O2 during pre-oxygenation.

    An arterial bloodgas with the patient in the supine position breathing air will be analysed with regards to PaO2 and correlated to the rise in end-tidal O2 concentration during pre-oxygenation.

    Measured: 5 minutes.

Secondary outcomes (1)
  1. Age and the rise in end-tidal O2 during pre-oxygenation.

    Age will be correlated to the rise in end-tidal O2 during pre-oxygenation.

    Measured: 5 minutes.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jan 2018
  2. Study start30 Oct 2018
  3. Primary completion17 Sep 2021
  4. Study completion29 Sep 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (actual)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT03395782
Sponsor's protocol ID
20170517-184
Status last verified
Sep 2021
First submitted
4 Jan 2018
Last updated
30 Sep 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kang H, Park HJ, Baek SK, Choi J, Park SJ. Effects of preoxygenation with the three minutes tidal volume breathing technique in the elderly. Korean J Anesthesiol. 2010 Apr;58(4):369-73. doi: 10.4097/kjae.2010.58.4.369. Epub 2010 Apr 28.

    PubMed 20508794
  • Sum Ping SJ, Makary LF, Van Hal MD. Factors influencing oxygen store during denitrogenation in the healthy patient. J Clin Anesth. 2009 May;21(3):183-9. doi: 10.1016/j.jclinane.2008.07.004.

    PubMed 19464611
  • Milic-Emili J, Torchio R, D'Angelo E. Closing volume: a reappraisal (1967-2007). Eur J Appl Physiol. 2007 Apr;99(6):567-83. doi: 10.1007/s00421-006-0389-0. Epub 2007 Jan 20.

    PubMed 17237952
  • Gambee AM, Hertzka RE, Fisher DM. Preoxygenation techniques: comparison of three minutes and four breaths. Anesth Analg. 1987 May;66(5):468-70. No abstract available.

    PubMed 3578856
  • Larsson A, Ostberg E, Edmark L. Arterial partial pressure of oxygen as a marker of airway closure does not correlate with the efficacy of pre-oxygenation: A prospective cohort study. Eur J Anaesthesiol. 2023 Sep 1;40(9):699-706. doi: 10.1097/EJA.0000000000001869. Epub 2023 Jun 30.

    PubMed 37395501

Questions about this trial

What is this clinical trial studying?

An observational study of Airway Complication of Anesthesia, run by Region Västmanland at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PaO2 breathing air before start of pre-oxygenation and the rise in end-tidal O2 during pre-oxygenation. (time frame: 5 minutes.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03395782, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in